sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Remifentanil

Medicine

Remifentanil

ULTIVA is indicated for intravenous (IV) administration: As an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
  • As an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures.
  • For continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting.
  • As an analgesic component of monitored anesthesia care in adult patients.
Do not take if
  • For epidural or intrathecal administration due to the presence of glycine in the formulation.
  • In patients with hypersensitivity to remifentanil (e.g., anaphylaxis).

What it is used for

Remifentanil hydrochloride (HCl) for injection is indicated for intravenous (IV) administration:

  • As an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures.
  • For continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting.
  • As an analgesic component of monitored anesthesia care in adult patients.

Side effects, and when to stop

The following serious adverse reactions are described, or described in greater detail, in other sections:

  • Addiction, Abuse, and Misuse
  • Respiratory Depression in Spontaneously Breathing Patients
  • Interactions with Benzodiazepines or other CNS Depressants
  • Serotonin Syndrome
  • Skeletal Muscle Rigidity
  • Bradycardia
  • Hypotension
  • Biliary Tract Disease
  • Seizures

Who should not take it

Remifentanil HCl is contraindicated:

  • For epidural or intrathecal administration due to the presence of glycine in the formulation.
  • In patients with hypersensitivity to remifentanil (e.g., anaphylaxis).

Other medicines and interactions

Table 18 includes clinically significant drug interactions with remifentanil HCl. Table 18: Clinically Significant Drug Interactions with Remifentanil HCl

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Remifentanil; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/remifentanil

APA 7th

sofidex. (2026, August 3). Remifentanil. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/remifentanil

AMA 11th

Remifentanil. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/remifentanil

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.